A retrospective study assessing cutaneous adverse events associated with ipilimumab and tremelimumab in patients with acneiform eruptions
Latest Information Update: 17 Jul 2020
At a glance
- Drugs Ipilimumab (Primary) ; Tremelimumab (Primary)
- Indications Cancer
- Focus Adverse reactions
- 17 Jul 2020 New trial record
- 01 Jun 2020 Results published in the Supportive Care in Cancer